European Medicines Agency
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
European Medicines Agency
Jul 18, 2024, 10:05 |
Insight
EMA Joins FDA: Osimerintib + Chemo Approved for EGFR-Mutated Lung Cancer
Breaking News: EMA Joins FDA in Approving Osimerintib with Chemotherapy as a New 1st-Line Treatment…
Jul 10, 2024, 05:18 |
Insight
APEIRON Biologics to be Acquired by Ligand Pharmaceuticals for USD 100 Million
APEIRON Biologics AG (“APEIRON”), a leading Austrian biotech company, today announced that its shareholders have…
Jun 6, 2024, 02:05 |
Blog
Miguel Bronchud: Parallel thinking in developmental therapeutics
Miguel Bronchud, Co-Founder of Regenerative Medicine Solutions, shared on LinkedIn: ''What we learned in the…
May 25, 2024, 10:05 |
Insight
Marco Donia: The Role of PD-L1 Assessment in Dual Checkpoint Inhibition for Melanoma
Marco Donia, Clinical Research Associate Professor at the University of Copenhagen, shared on LinkedIn: "The…
May 15, 2024, 13:42 |
Blog
Key Insights From The Cancer Medicines Forum Workshop - EORTC
EORTC – European Organisation for Research and Treatment of Cancer made the following post on LinkedIn:…
Apr 25, 2024, 15:57 |
Blog
Join the 14th ACCELERATE Paediatric Strategy Forum
ACCELERATE shared a post on LinkedIn: "Expression of interest is now open! Join us for the…
Apr 18, 2024, 16:53 |
Societies
Dominika Misztela: Econ Cell and Gene Therapy Summit - Day 1 highlight
Dominika Misztela, Director of Global Regulatory Affairs Science, Policy, and Intelligence of CSL Brussels Metropolitan…
Apr 14, 2024, 22:37 |
Insight
Vivek Subbiah: Prostate cancer cases are projected to double to 2.9 million per year by 2040
Quoting Vivek Subbiah's post on X/Twitter: "Prostate cancer cases are projected to double to 2.9…
Apr 14, 2024, 03:32 |
Career
Vivek Subbiah: Sending massive congratulations to the incredible Patricia M. LoRusso for her Presidency at the American Association for Cancer Research!
Vivek Subbiah shared a post on X/Twitter: "Sending massive congratulations to the incredible AACR President,…
Apr 14, 2024, 03:08 |
Societies
Vivek Subbiah: The future of cancer research shines brightly!
Quoting Vivek Subbiah on X/Twitter: "The future of cancer research shines brightly! It was an honor…
Apr 14, 2024, 02:26 |
Insight
Vivek Subbiah: A pan-cancer analysis of the microbiome in metastatic cancer
Quoting Vivek Subbiah on X/Twitter: "A pan-cancer analysis of the microbiome in metastatic cancer: Cell.…
Apr 12, 2024, 16:21 |
Societies
Vivek Subbiah: Where does the AACR24 Plenary Chair work with the ASCO Plenary Chair?
Vivek Subbiah shared a post on LinkedIn: "Where does the American Association for Cancer Research AACR24 Plenary…
Apr 8, 2024, 07:46 |
Positive
Vivek Subbiah: OUR ACTION LEADER who keeps me inspired! Incredibly proud!
Vivek Subbiah recently shared on his LinkedIn page: "Before heading to the American Association for…
Mar 27, 2024, 23:42 |
Blog
Speakers for the next open ALADDIN webinar are confirmed! - ALADDIN Education
ALADDIN Education posted on LinkedIn: “Speakers for the next open ALADDIN webinar are confirmed! Dominik Karres…
Mar 16, 2024, 15:39 |
Blog
Sarah Sammons: DPYD testing is required before our pharmacy will dispense capecitabine
Sarah Sammons, Breast Medical Oncologist at Dana-Farber’s Breast Oncology Center, shared a post by Vivek Subbiah…
Mar 8, 2024, 15:14 |
Blog
Vivek Subbiah: Harnessing the potential of basket trials
Vivek Subbiah recently shared a post on X/Twitter: "Revolutionizing cancer drug development: Harnessing the potential…
Feb 28, 2024, 14:51 |
Blog
Ensure you secure your spot at the Cancer Medicines Forum workshop - EORTC
EORTC - European Organisation for Research and Treatment of Cancer made the following post on…
Feb 26, 2024, 15:38 |
Blog
ALADDIN Education: Applications for the ALADDIN Education 360° rotation with the European Medicines Agency are now open
ALADDIN Education posted on LinkedIn: "Interested in gaining practical experience in regulatory affairs and drug…
Feb 18, 2024, 14:12 |
Blog
Don't miss the Cancer Medicines Forum workshop! - EORTC
Quoting EORTC - European Organisation for Research and Treatment of Cancer on LinkedIn "Don't miss…
Feb 10, 2024, 19:05 |
Blog
Exciting updates from Session II at ACCELERATE cure 2024 Annual Conference - ACCELERATE Multi-Stakeholder Platform
ACCELERATE Multi-Stakeholder Platform shared on LinkedIn: "Exciting updates from Session II at ACCELERATE cure 2024 Annual…
Feb 1, 2024, 04:54 |
Blog
Chris Boshoff: The European Medicines Agency (EMA) has accepted our application in collaboration with Astellas Pharma US and Merck for a combination therapy for advanced Urothelial Cancer
Jan 14, 2024, 14:49 |
Blog
Chris Boshoff: The European Medicines Agency approved our Prostate Cancer combination for men living with metastatic castration-resistant prostate cancer
Chris Boshoff, Chief Oncology Officer and Executive Vice President at Pfizer, shared on LinkedIn: "I’m proud…
Dec 24, 2023, 18:05 |
Insight
Marco Donia: Adjuvant Anti-PD-1 Immunotherapy for Resected Melanoma: Update December 2023
Marco Donia, Associate Professor at National Center for Cancer Immune Therapy, Denmark, shared on LinkedIn:…
Dec 7, 2023, 19:14 |
Blog
Vivek Subbiah: Delighted to meet with the rising young oncology star from Brazil, Juliana Beal!
Vivek Subbiah shared a post on his X/Twitter page: "Such a delight to meet with…
Dec 4, 2023, 15:54 |
Blog
Vivek Subbiah: Tissue-agnostic precision medicine takes the spotlight!
Vivek Subbiah shared a post on his LinkedIn page: "Hot off the press- Friday Motivation!…
Nov 26, 2023, 17:48 |
Blog
Penilla Gunther: Round table discussion in Amsterdam about the Pharma Package and the exoression ”unmet medical needs”
Penilla Gunther, Founder of FOKUS Patient, shared on LinkedIn: "Invited by Faiez Zannad and the…
Nov 25, 2023, 16:40 |
Blog
Penilla Gunther: Day 2 in Amsterdam at the Cardiovascular Round Table
Penilla Gunther recently shared on LinkedIn: "Day 2 in Amsterdam at the Cardiovascular Round Table…
Nov 24, 2023, 16:39 |
Blog
Denis Horgan: MEPs, EMA and European Commission explore missed opportunities for earlier and better healthcare
Denis Horgan, Executive Director from the European Alliance of Personalised Medicine (EAPM), shared a post…
Nov 23, 2023, 15:25 |
Blog
Emer Cooke: Children are not small adults, and they have specific medical needs that require tailored solutions
Emer Cooke, Executive Director of the European Medicines Agency, shared on LinkedIn: "Children deserve the…
Nov 1, 2023, 09:45 |
Insight
Alessandro Inno: A case of a very elderly patient with MET-exon 14 mutant NSCLC with meaningful and durable benefit from first-line tepotinib, with an acceptable safety profile
Oct 5, 2023, 17:41 |
Blog
Vivek Subbiah: Mark your calendars if you are attending the ESMO MAP23 meeting in Paris, France this week, Oct 4-6.
Quoting Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, on…
Jun 19, 2023, 20:15 |
Drugs
Traditional trial designs and regulatory processes face hurdles in keeping up with the pace of scientific discovery, artificial intelligence, big data and real-world data
All:
32
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube